These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33463405)

  • 1. Assessing the Appropriateness of the EQ-5D for Duchenne Muscular Dystrophy: A Patient-Centered Study.
    Crossnohere NL; Fischer R; Lloyd A; Prosser LA; Bridges JFP
    Med Decis Making; 2021 Feb; 41(2):209-221. PubMed ID: 33463405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
    Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D
    Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L.
    Audhya IF; Szabo SM; Bever A; O'Sullivan F; Malone DC; Feeny D; Neumann P; Iannaccone ST; Jayasinghe P; Gooch KL
    J Patient Rep Outcomes; 2023 Dec; 7(1):132. PubMed ID: 38100005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DISEASE BURDEN OP DUCHENNE MUSCULAR DYSTROPHY PATIENTS AND THEIR CAREGIVERS].
    Péntek M; Herczegfalvi Á; Molnár MJ; Szőnyi LP; Kosztolányi G; Pfliegler G; Melegh B; Boncz I; Brodszky V; Baji P; Szegedi M; Pogány G; Gulácsi L
    Ideggyogy Sz; 2016 Mar; 69(5-6):183-93. PubMed ID: 27468608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.
    König HH; Brettschneider C; Lühmann D; Kaduszkiewicz H; Oey A; Wiese B; Werle J; Weyerer S; Fuchs A; Pentzek M; Conrad I; Röhr S; Weeg D; Bickel H; Heser K; Wagner M; Scherer M; Maier W; Riedel-Heller SG; Hajek A
    Qual Life Res; 2020 Dec; 29(12):3223-3232. PubMed ID: 32851600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
    Jankowska A; Młyńczak K; Golicki D
    Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EQ-5D Brazilian population norms.
    Santos M; Monteiro AL; Santos B
    Health Qual Life Outcomes; 2021 Jun; 19(1):162. PubMed ID: 34112207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
    Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
    Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
    Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
    Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
    Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of EQ-5D-5L in stroke.
    Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
    Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
    Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.